A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Cardiologists need to embrace the wave of new drugs, say experts, particularly since they can reduce the risk of CVD.

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side effect: family members who are not taking the drugs are changing their ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not uncommon for individuals to seek out a weight management aid, such as a ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, ...

A new study suggests that popular weight loss medications could significantly benefit patients awaiting kidney transplants.

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...